Ardent Health Inc (NYSE:ARDT)
$ 10.77 -0.16 (-1.46%) Market Cap: 1.54 Bil Enterprise Value: 3.61 Bil PE Ratio: 11.40 PB Ratio: 1.15 GF Score: 37/100

Q4 2025 Ardent Health Inc Earnings Call Transcript

Mar 05, 2026 / 03:00PM GMT
Release Date Price: $9.44 (-2.07%)

Key Points

Positve
  • Ardent Health Inc (ARDT) reported its highest ever revenue, EBITDA, and operating cash flow in 2025, with a 6% increase in full-year revenue to $6.3 billion.
  • The company's IMPACT program initiatives led to a 9% growth in adjusted EBITDA and a 20 basis point margin expansion for 2025.
  • Ardent Health Inc (ARDT) generated significant operating cash flow of $471 million in 2025, marking a 49% increase from 2024.
  • The company successfully reduced contract labor expenses by 26% in the fourth quarter, contributing to overall cost savings.
  • Ardent Health Inc (ARDT) strengthened its balance sheet by increasing cash reserves by approximately $150 million and reducing lease-adjusted net leverage to 2.5 times.
Negative
  • Professional fees and payer denials remained elevated, with professional fee growth in the high single-digit range for 2025.
  • The company anticipates a potential $35 million headwind in 2026 due to exchange disruptions from the expiration of enhanced subsidies.
  • Ardent Health Inc (ARDT) is not factoring in any significant improvement in payer denial trends for 2026, despite some stabilization in Q4 2025.
  • The timing of the last payroll cycle in 2026 is expected to create a $50 million cash flow headwind year-over-year.
  • The company faces ongoing industry challenges, including rate pressures and elevated professional fees, which are expected to persist into 2026.
Operator

Good morning, and thank you for standing by. My name is John, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ardent Health fourth quarter and full year 2025 earnings call. (Operator Instructions) I would now like to turn the call over to Dave Styblo, Senior Vice President of Investor Relations. Please go ahead.

Dave Styblo
Ardent Health Inc - Senior Vice President, Investor Relations Contact

Thank you, operator, and welcome to Ardent Health's fourth quarter 2025 earnings conference call. Joining me today is Ardent President and Chief Executive Officer, Marty Bonick; and Chief Financial Officer, Alfred Lumsdaine. Marty and Alfred will provide prepared remarks, and then we will open the line to questions.

Before I turn the call over to Marty, I want to remind everyone that today's discussion contains forward-looking statements about future business and financial expectations. Actual results may differ significantly from those projected in today's forward-looking statements due to various risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot